Search For "arthritis patients"  Robotic Knee Replacement: Precision, Personalization and
MUMBAI (NewsRise) -- The U.S. drug regulator has raised more concerns about the manufacturing practices at India's Dr. Reddy's Laboratories, dealing a fresh blow to the country's second-largest drug m
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories, India's second-largest pharmaceutical company, warned of a bleak outlook amid delayed approvals for key products in the U.S., after reporting a better-th
MUMBAI (NewsRise) -- A U.S. federal court has found that Dr. Reddy's Laboratories' generic formulation of anti-nausea injection drug Aloxi infringes certain patents, blocking its launch in the largest
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories reported a smaller-than-expected fourth-quarter net income as competition and lack of new products in the U.S., weighed on India's second-largest pharmace
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories said first-quarter net income slumped 57% from a year earlier, as rising pricing pressure in the U.S. and a temporary contraction in stocks in domestic ma
MUMBAI (NewsRise) -- Indian shares rose for a fourth day on Tuesday, tracking positive regional markets, and as heavyweight Reliance Industries gained after Goldman Sachs reportedly raised its target
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories, India's second-largest drug maker, reported a better-than-expected second-quarter net income on Tuesday, as improved efficiency in its operations helped
MUMBAI (NewsRise) -- Indian shares continued to underperform their Asian peers, ending little changed on Wednesday amid concerns over the government's fiscal condition. EquitiesIndia stocks little cha
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories, India's second-largest drug maker, reported a bigger-than-expected 29% drop in quarterly net profit, weighed by a one-time charge related to changes in U
MUMBAI (NewsRise) -- Indian shares rose this week, helped by a rally on Friday after exit polls predicted Prime Minister Narendra Modi's Bharatiya Janata Party to win Gujarat state elections. StocksIn
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories reported a surprise 3% drop in quarterly net profit, as the Indian drug maker continued to grapple with pricing pressure in the U.S. CompaniesDr. Reddy's
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories resumed sales of the generic version of U.K.-based Indivior's blockbuster opioid treatment Suboxone film in the U.S., a day after an appeals court lifted
MUMBAI (NewsRise) -- Dr. Reddy's Laboratories reported a better-than-expected 65% surge in third-quarter net profit, as the Indian drug maker gained from the sale of a unit and lower taxes. CompaniesD
Indonesia's Kalbe Farma works toward 'health ecosystem' in search of growth Investor attention turns to next week's federal budget One-time charge on U.S. tax liabilities erodes net income Top-tier bi
Fewer developers and tight supply pushing up prices Possible lawsuits, ESG investors prompted Obayashi to seek leniency Environmental protests come as Thailand and Myanmar face challenge to meet power
With prices for generics under pressure, biosimilars have become the next opportunity Buybacks also helping to boost shareholder returns US acquisition would lift Japanese paint maker to fourth place